相关实验视频

Updated: Jun 15, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

在转移性黑色素瘤中进行冷和后进展免疫检查点抑制:II期试验

Meghan J Mooradian^1,2, Florian J Fintelmann^3,4, Thomas J LaSalle^5,6,7

¹Division of Medical Oncology, Massachusetts General Hospital, Boston, MA, USA. mmooradian@mgh.harvard.edu.

Nature communications

|August 27, 2024

概括

结合免疫检查点抑制 (ICI) 的冷处理显示出治疗晚期黑色素瘤的前景. 这种方法是安全的和可行的,有可能增强抗瘤反应在患者耐药标准ICI治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
最少侵入性的手术

背景情况:

图像引导的皮肤化是标准的最小侵入性瘤治疗方法.
免疫检查点抑制 (ICI) 是不可切除黑色素瘤的关键治疗方法.
对ICI耐药的瘤是一个重大的临床挑战.

研究的目的:

调查结合冷和持续ICI结合的安全性和有效性,在ICI进展的不可切除黑色素瘤患者中.
评估冷消毒的潜力,以修改瘤的免疫微环境,并产生抗瘤反应.

主要方法:

进行了一项非随机的,单中心的II期研究 (NCT03290677).
患有无法切除的黑色素瘤的患者在ICI上进展,经历了转移的冷化.
在冷后,ICI继续进行至少两个额外的循环.

主要成果:

该研究满足了安全性和可行性的主要终点.
结合策略的客观响应率为23.5%.
在非消去的病变中观察到41%的疾病控制率 (4部分响应,3稳定疾病).

结论:

将冷与免疫检查点抑制相结合,对于晚期黑色素瘤来说是安全和可行的.
这种协同方法显示出在ICI耐火性瘤中产生抗瘤反应的潜力.
需要对这种治疗组合进行进一步的研究.

更多相关视频

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.